Zika

19 registered clinical trials studyying Zika — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities NCT07517731	University of Freiburg	N/A
Enrolling By Invitation	Xpert® Tropical Fever Test on GeneXpert® Edge X System NCT07520279	Cepheid	—
Terminated	Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale NCT06595745	Michigan State University	N/A
Completed	Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine C NCT06334393	Valneva Austria GmbH	Phase 1
Completed	Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu NCT05153018	Institut Pasteur	N/A
Suspended	Baromètre Santé Adulte 2021-2022 NCT05218304	Agence Sanitaire et Sociale de Nouvelle Calédonie	N/A
Recruiting	Virological and Immunological Determinants of Arbovirus Infection in New Caledonia NCT04619823	Institut Pasteur	N/A
Completed	Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia NCT04434846	National Institute of Allergy and Infectious Diseases (NIAID)	—
Unknown	Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Fo NCT04672577	Patricia Schlagenhauf	—
Completed	Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases NCT04343521	Emory University	N/A
Completed	Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico. NCT04440774	University of Oxford	Phase 1
Recruiting	Genetic Evolution of Arboviruses in New Caledonia Between 1995 and 2024 and Impact of Wolbachia NCT04615364	Institut Pasteur	—
Completed	Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001) NCT04015648	University of Oxford	Phase 1
Completed	International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy NCT04118738	Westat	—
Completed	Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating NCT06268691	Rocio Cardenas Sanchez	N/A
Completed	Defining Skin Immunity of a Bite of Key Insect Vectors in Humans NCT03641339	National Institute of Allergy and Infectious Diseases (NIAID)	N/A
Completed	Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study NCT02937233	Kathryn Stephenson	Phase 1
Completed	GLS-5700 in Dengue Virus Seropositive Adults NCT02887482	GeneOne Life Science, Inc.	Phase 1
Recruiting	Screening for LID Clinical Studies Unit Healthy Volunteer Protocols NCT01386424	National Institute of Allergy and Infectious Diseases (NIAID)	—